--- title: Buy Namzaric (Donepezil/Memantine) 5/5mg Pills Online description: Namzaric (Donepezil/Memantine) 5/5mg pills provide combination therapy for Alzheimer's symptoms. Secure ordering and reliable delivery. type: product language: en url: https://medsforsale.net/buy-namzaric-online-en availability: in_stock price_min: 63.99 price_max: 292.99 currency: USD offers: - name: 5/5mg x 30 pills price: 63.99 - name: 5/5mg x 60 pills price: 118.99 - name: 5/5mg x 90 pills price: 164.99 - name: 5/5mg x 120 pills price: 210.99 - name: 5/5mg x 180 pills price: 292.99 --- # Buy Namzaric (Donepezil/Memantine) 5/5mg Pills Online Namzaric is a combination medication containing Donepezil and Memantine, designed to treat moderate to severe dementia associated with Alzheimer's disease. By combining a cholinesterase inhibitor with an NMDA receptor antagonist, it addresses multiple pathways in the brain to help manage cognitive decline. It is intended for patients who are already stabilized on both individual components. Access Namzaric through our reliable pharmacy in 5/5mg pills. ## Pricing and Options | Dosage | Pack Size | Price (USD) | Price Per Pill | Status | | :--- | :--- | :--- | :--- | :--- | | **5/5mg** | 30 pills | **$63.99** | $2.13 | In Stock | | **5/5mg** | 60 pills | **$118.99** | $1.98 | In Stock | | **5/5mg** | 90 pills | **$164.99** | $1.83 | In Stock | | **5/5mg** | 120 pills | **$210.99** | $1.76 | In Stock | | **5/5mg** | 180 pills | **$292.99** | $1.63 | In Stock | [Buy Now](https://medsforsale.net/buy-namzaric-online-en) ## Introduction Namzaric is a fixed-dose combination tablet that contains two centrally acting agents: donepezil, an acetylcholinesterase inhibitor, and memantine, an N-methyl-D-aspartate (NMDA) receptor antagonist. The product is indicated for the treatment of moderate to severe Alzheimer’s disease when monotherapy with either component does not provide sufficient symptom control. Each tablet delivers 5 mg of donepezil and 5 mg of memantine. It belongs to the therapeutic classes of cholinesterase inhibitors and NMDA-receptor antagonists, respectively. The medication is manufactured by Janssen Pharmaceuticals and is approved in the United States, the European Union, and many other jurisdictions. In addition to its primary indication, clinicians occasionally consider Namzaric for off-label neurologic conditions, although such use is not authorized by regulatory agencies. ## What is Namzaric? Namzaric is a prescription-only oral tablet that combines two FDA-approved Alzheimer’s disease agents in a single pill. The combination simplifies dosing for patients who would otherwise need to take separate tablets of donepezil (commonly sold as Aricept) and memantine (commonly sold as Namenda). By delivering both drugs together, Namzaric aims to improve adherence and provide a synergistic effect on cognition and daily functioning. The product was developed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, and received its first regulatory approval in the United States in 2014. The tablet is available in a 5 mg/5 mg strength, which corresponds to the lowest effective doses of each component and allows titration if needed. ## How Namzaric Works Donepezil increases the concentration of acetylcholine in the synaptic cleft by inhibiting the enzyme acetylcholinesterase that normally degrades this neurotransmitter. Higher cholinergic activity is associated with improved attention, learning, and memory in the damaged brain of Alzheimer’s patients. Memantine binds to the NMDA receptor-associated ion channel at a site distinct from the glutamate binding site. By blocking excessive calcium influx caused by over-activation of NMDA receptors, memantine helps to reduce excitotoxic neuronal injury that contributes to cognitive decline. When used together, the cholinergic enhancement of donepezil and the neuroprotective effect of memantine provide complementary mechanisms. Clinical trials have shown that the combination can yield modest but statistically significant improvements in cognition, functional abilities, and caregiver burden compared with either agent alone. The onset of action for donepezil typically occurs within 2-4 weeks, while memantine may require 4-6 weeks to reach steady-state therapeutic effects. Both drugs are eliminated primarily by renal excretion; donepezil has a half-life of about 70 hours, and memantine’s half-life is approximately 60-80 hours, allowing once-daily dosing. ## Conditions Treated with Namzaric - **Moderate to severe Alzheimer’s disease** - The only indication approved by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). The combination is prescribed when patients have progressed beyond mild disease and when monotherapy fails to maintain cognition or activities of daily living. The therapeutic benefit arises from the dual action on cholinergic neurotransmission and glutamatergic excitotoxicity, which together address two major pathophysiological pathways of Alzheimer’s disease. ## Off-Label and Investigational Uses of Namzaric - **Vascular dementia** - Small open-label studies have examined the addition of memantine to cholinesterase inhibitors in mixed dementia, reporting modest improvements in executive function. However, robust randomized trials are lacking, and the use remains off-label. - **Parkinson’s disease dementia (PDD)** - Some clinicians have used donepezil-memantine combinations for PDD because both cholinergic deficits and glutamatergic dysregulation are implicated. Evidence consists principally of case series; regulatory approval has not been granted. - **Mild cognitive impairment (MCI) with biomarker evidence of Alzheimer’s pathology** - Early-phase trials are investigating whether early combination therapy can delay conversion to dementia. Results are preliminary, and routine use is not recommended outside research protocols. *All off-label applications should be undertaken only under the direct supervision of a qualified healthcare professional. The safety and efficacy of Namzaric for these conditions have not been confirmed by FDA, EMA, or comparable agencies.* ## Is Namzaric the Right Medication for You? Namzaric is most appropriate for adults with a confirmed diagnosis of moderate to severe Alzheimer’s disease who have already been tolerated on both donepezil and memantine individually. It is especially useful when pill burden hampers adherence, as the fixed-dose formulation reduces the number of tablets taken each day. **Contraindications and cautions** include: - Known hypersensitivity to donepezil, memantine, or any tablet excipients. - Severe renal impairment (creatinine clearance < 30 mL/min) - dose adjustment of memantine may be required, and some clinicians avoid the combination. - Uncontrolled cardiac conduction abnormalities (e.g., sick sinus syndrome, second- or third-degree heart block) because donepezil can exacerbate bradyarrhythmias. - History of seizure disorders - memantine lowers seizure threshold in rare cases. Patients with hepatic impairment, peptic ulcer disease, or bladder obstruction should be monitored closely, but these conditions are not absolute contraindications. Clinical decision-making should incorporate the patient’s overall health, comorbidities, current medication regimen, and personal treatment goals. ## Risks, Side Effects, and Interactions ### Common - **Gastrointestinal:** nausea, vomiting, diarrhea, dyspepsia, loss of appetite. - **Central nervous system:** headache, dizziness, insomnia, vivid dreams. - **Musculoskeletal:** muscle cramps or pain. These events usually appear within the first weeks of therapy and often lessen with continued use or dose titration. ### Rare -iac:** sinus bradycardia, atrioventricular block, syncope. - **Psychiatric:** agitation, anxiety, mood swings, visual hallucinations. - **Dermatologic:** rash, pruritus, urticaria. Rare events warrant prompt evaluation but are not typically life-threatening. ### Serious - **Seizures** - memantine may lower seizure threshold, particularly in patients with a prior seizure history. - **Severe hypersensitivity reactions** - anaphylaxis, Stevens-Johnson syndrome, or toxic epidermal necrolysis. - **Liver injury** - although uncommon, cholinesterase inhibitors have been linked to elevated transaminases. Any serious or rapidly worsening symptom should trigger immediate medical attention. #### Drug-Drug Interactions - **Anticholinergic agents** (e.g., diphenhydramine, tricyclic antidepressants) may blunt the cognitive benefits of donepezil. - **Strong CYP3A4 inhibitors** (e.g., ketoconazole, clarithromycin) can increase plasma concentrations of donepezil, raising the risk of bradycardia. - **NMDA-receptor antagonists** (e.g., amantadine) may potentiate memantine’s effects and increase neurotoxicity. - **Renally cleared drugs** (e.g., digoxin) may compete with memantine for tubular secretion; dose adjustment may be necessary in renal impairment. #### Drug-Food Interactions - Donepezil can be taken with or without food; however, taking the tablet with a light snack may reduce gastrointestinal upset. - Alcohol may exacerbate dizziness and sedation, especially when combined with memantine’s CNS effects. Patients should limit or avoid alcohol while on Namzaric. ## Use: Dosing, Missed Dose, Overdose -Standard starting dose:** one tablet (5 mg donepezil/5 mg memantine) taken once daily, preferably in the evening. - **Titration:** Some clinicians increase to 10 mg/10 mg after 4-6 weeks if tolerated and if clinical response is insufficient. The higher strength is available as a separate tablet; concurrent use of two 5/5 mg tablets is discouraged without physician guidance. - **Missed dose:** If a dose is forgotten within 12 hours of the scheduled time, take it as soon as remembered. If more than 12 hours have passed, skip the missed tablet and resume the regular once-daily schedule. Do not double-dose. - **Overdose:** Symptoms may include severe nausea, vomiting, dizziness, seizures, or cardiac arrhythmias. Seek emergency medical care immediately. Supportive measures such as gastric lavage, activated charcoal, and cardiac monitoring are standard. - **Administration considerations:** The tablet should be swallowed whole with a full glass of water. Crushing or chewing may alter absorption. Avoid simultaneous intake of large amounts of caffeine or stimulant medications, as they can increase the risk of insomnia and tachycardia. Patients should refrain from operating heavy machinery or driving until they know how Namzaric affects them, particularly during the first few weeks. ## FAQ - **What should I do if I travel abroad with Namzaric?**   Carry the medication in its original labeled container, along with a copy of the prescription and a physician’s letter if required. Keep tablets in your carry-on luggage to protect them from temperature extremes and to comply with customs regulations. - **Does Namzaric interact with herbal supplements such as ginkgo biloba?**   Ginkgo has mild antiplatelet activity, which can increase bleeding risk when combined with certain cardiovascular drugs. While no direct pharmacokinetic interaction with donepezil or memantine is documented, discuss all supplements with your clinician to avoid unforeseen effects. - **How long does a Namzaric tablet stay stable after the bottle is opened?**   The tablet is stable for up to 24 months when stored at 20-25 °C (68-77 °F) away from moisture and light. Once the bottle is opened, maintain the same conditions; do not store tablets in the bathroom or refrigerator. - **Are there any visible differences between brand-name and generic Namzaric tablets?**   Generic tablets may differ in shape, color, or imprint but contain identical amounts of donepezil and memantine. Inactive ingredients such as fillers or dyes can vary; this is generally clinically insignificant but may matter for patients with specific allergies. - **Can I take Namzaric if I have a pacemaker?**   Donepezil can cause bradycardia, which may be of concern in patients with existing conduction devices. Most pacemaker patients tolerate the medication, but a cardiology review is advisable before initiation. - **Is Namzaric safe for patients with moderate kidney disease?**   Memantine is primarily excreted unchanged by the kidneys. In patients with creatinine clearance between 30-60 mL/min, a dose reduction to 5 mg daily is often recommended. Severe renal impairment usually contraindicates the combination. - **What is the difference between Namzaric and separately prescribed Donepezil + Memantine?**   The clinical efficacy is comparable; the primary distinction is the convenience of a single tablet, which can improve adherence. Some clinicians prefer separate tablets to fine-tune individual doses. - **Does taking Namzaric affect laboratory tests, such as liver function panels?**   Donepezil may cause mild, transient elevations in hepatic transaminases. Routine monitoring is not mandatory but may be considered in patients with pre-existing liver disease. - **Can I use Namzaric during hospice care?**   Treatment goals in hospice focus on comfort. If cognitive symptoms cause distress for the patient or caregivers, continuation of Namzaric may be appropriate after careful discussion of benefits versus pill burden. - **Is there any evidence that Namzaric prolongs survival in Alzheimer’s disease?**   Current randomized trials have demonstrated modest improvements in cognition and functional outcomes but have not shown a statistically significant effect on overall mortality. Survival benefits remain unproven. - **What should I do if I develop a rash after starting Namzaric?**   A skin rash may indicate a hypersensitivity reaction. Discontinue the medication and seek medical evaluation promptly, especially if the rash is widespread, accompanied by fever, or involves mucous membranes. ## Glossary **Acetylcholinesterase inhibitor** : A drug class that blocks the enzyme responsible for breaking down acetylcholine, thereby increasing its concentration in the brain and improving neurotransmission. **NMDA-receptor antagonist** : A compound that reduces excessive activation of the NMDA-type glutamate receptor, helping to prevent calcium-mediated neuronal damage. **Renal clearance** : The volume of plasma from which a substance is completely removed by the kidneys per unit time, influencing dosing in patients with kidney disease. **Pill burden** : The total number of medication tablets a patient must take each day; a high pill burden can impair adherence. ## Buying Namzaric from [our online pharmacy](https://medsforsale.net/buy-namzaric-online-en) Patients who encounter difficulty obtaining Namzaric through conventional channels can source the medication from **[our online pharmacy](https://medsforsale.net/buy-namzaric-online-en)**. We partner with licensed overseas pharmacies that adhere to strict quality-control standards, ensuring that each tablet meets the same regulatory specifications as those supplied in the United States and the European Union. Key advantages of ordering through our service include: - **Cost-effectiveness:** Prices are set close to manufacturer cost, providing a substantial saving compared with retail pharmacy rates. - **Verified quality:** All shipments originate from accredited suppliers who follow Good Manufacturing Practices (GMP) and undergo third-party testing for potency and purity. - **Discrete delivery:** Packages are packaged in unmarked envelopes and shipped via secure courier services, protecting your privacy throughout the process. - **Reliable logistics:** We offer express shipping (typically 7 days) for urgent needs and standard airmail (approximately 3 weeks) for routine refills, with tracking available for every order. Our pharmacy broker model enables us to import medication that may not be stocked locally, helping patients maintain uninterrupted therapy. The service is designed to be straightforward: you select the desired quantity, provide a valid prescription copy, and our team coordinates fulfillment, customs clearance, and delivery. By choosing **[our online pharmacy](https://medsforsale.net/buy-namzaric-online-en)**, you benefit from an affordable, verified, and private way to obtain Namzaric when other options are limited. ## Disclaimer The information presented about **Namzaric** is intended for general educational purposes and does not replace personalized medical advice. Treatment choices, including any off-label applications, must be made under the guidance of a qualified healthcare professional. Readers are presumed to be responsible adults capable of informed health decisions. [our online pharmacy](https://medsforsale.net/buy-namzaric-online-en) supplies **Namzaric** to individuals who may face limited access through traditional pharmacies or insurance plans, or who seek a financially viable generic option. Always discuss any medication changes with your clinician before initiating, adjusting, or stopping therapy.